Cogent Biosciences, Inc.
COGT
3 insider filings · Latest: Apr 1, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Apr 1 1:30 AM | Fairmount Healthcare Fund II L.P. | Proposed Sale | 7,000,000 | $34.66 | $242.6M | — | View → |
| Mar 31, 2026 | Apr 1 1:30 AM | Fairmount Funds Management LLCDirector | Sale | 7,000,000 | $34.66 | $242.6M | 5,503,418(I) | View → |
| Jan 22, 2026 | Jan 23 1:09 AM | Fairmount Funds Management LLCDirector | Sale | 3,500,000 | $36.40 | $127.4M | 5,503,418(I) | View → |
| Jan 22, 2026 | Jan 23 1:05 AM | Fairmount Healthcare Fund II L.P. | Proposed Sale | 3,500,000 | $36.40 | $127.4M | — | View → |
| Dec 26, 2025 | Dec 29 2:27 PM | JESSICA SACHS | Proposed Sale | 82,642 | $38.70 | $3.2M | — | View → |
| Dec 26, 2025 | Dec 29 2:08 PM | JOHN ROBINSON | Proposed Sale | 90,000 | $38.74 | $3.5M | — | View → |
| Dec 26, 2025 | Dec 29 2:06 PM | JOHN GREEN | Proposed Sale | 77,000 | $38.68 | $3.0M | — | View → |
| Dec 26, 2025 | Dec 29 2:05 PM | EVAN D KEARNS | Proposed Sale | 65,000 | $38.70 | $2.5M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 1, 2026 | Apr 3 8:01 PM | Karen Jean FerranteDirector | Grant/Award | 686 | $35.24 | 686(D) | View → |
| Mar 31, 2026 | Apr 1 1:30 AM | Fairmount Funds Management LLCDirector | Conversion | 28,000 | — | 39,414(I) | View → |